Erin McEvoy

Starting July 1, 2023, Australia will allow the use of psilocybin and 3,4-Methylenedioxymethamphetamine (MDMA) for therapeutic use in a medical setting to treat mental health conditions.

On February 2nd, Americans for Safe Access (ASA) held an editorial/press briefing to present their 2022 State of the States report, which graded each US state and four territories on patient access to cannabis. ASA is the nation’s largest member-based organization promoting safe and legal access to cannabis for therapeutic use and research.

In response to a call for comment on the proposed New York Office of Cannabis Management symbol, the Doctors for Cannabis Regulation submitted a letter outlining the design flaws of the proposed symbol and recommended adopting the International Intoxicating Cannabinoid Product Symbol instead.

A statement released on Thursday, January 26, 2023 from Dr. Janet Woodcock, the principal deputy commissioner of the Food and Drug Administration (FDA), announced that the FDA will work with Congress in formulating regulatory oversight to balance risk and access for products in the cannabidiol (CBD) market.

As access to edible cannabis increases for adults across the United States, children are also becoming more exposed as well.

Results from recently published survey studies on the effect of psilocybin and bipolar disorder offered support for the design of future clinical trials.

This 1 CME credit article evaluates evidence-based behavioral treatments, medications, and management strategies for cannabis use disorder.

A study published in January 2023 examined the effects of high and low doses of cannabigerol (CBG) on mice liver.

In late 2022, Leaf411, a cannabis-trained nurse guidance service, announced that they resumed their affordability program for patients struggling to pay for their medicine. In a recent update, Leaf411 outlined their continued response to requests for assistance they are receiving from across the country.

The study, which began before states started legalizing cannabis, published its results on the impact of a legal cannabis environment on cannabis use and alcohol use disorder.

Josee Guindon, DVM, PhD of Texas Tech University Health Sciences Center, was named as the recipient for this award, which recognizes dedication, perseverance, and skill in studying and researching the endocannabinoid system.

A farmer in Ireland who was arrested for growing and selling cannabis from his farm received a suspended sentence. Currently, cannabis is illegal in Ireland, except within a limited medical program.

A recent study from the University of Connecticut showed that the new “retipping” method of propagation resulted in quality cannabis flowers while using less space.

In results from a recent study, respondents reported that cannabis use led them to decrease their use of pharmacological treatments, including opioids.

Starting January 1, 2023, every insurance provider in Colombia must cover the costs of medical cannabis prescriptions for patients.

In December 2022, hospital staff in Hays, Kansas reported a terminally ill cancer patient to police for use of a cannabis vape pen.

Village Farms International, Inc., announced that starting later this month it will increase its global presence by beginning to ship cannabis products to the Israeli medical market.

In celebration of their 20th anniversary, Americans for Safe Access (ASA) held their 10th annual Unity Conference virtually from December 12-14, 2022. Here we present coverage of the third and final day of the conference.

In December, the US Department of Agriculture (USDA) announced an extension of the deadline for all hemp to be tested for tetrahydrocannabinol (THC) in Drug Enforcement Administration (DEA)-certified facilities only, citing a lack of approved laboratories.

In celebration of their 20th anniversary, Americans for Safe Access (ASA) held their 10th annual Unity Conference virtually from December 12-14, 2022. Here we present coverage of the second day of the conference.

In celebration of their 20th anniversary, Americans for Safe Access (ASA) held their 10th annual Unity Conference virtually from December 12-14, 2022.

Steve Ellmore, founder of The Unprescribed nonprofit, is a 20-year Air Force veteran. Here, Ellmore shares how his personal experience led him to become a medical cannabis patient and how his award-winning 2020 film, Unprescribed, documents the stories of veterans, cannabis advocacy, and the fight to end veteran suicide.

Recently, the Cannabis Nurses Network held their 2022 nurse appreciation celebration virtually. Events included an expo hall, a year in review, educational sessions and networking, and the awards ceremony.

Brittany Griner had been arrested in Moscow, Russia and sentenced to prison for cannabis possession, which is illegal in Russia.

On December 2nd, 2022, President Joe Biden signed the Medical Marijuana and Cannabidiol Research Expansion Act, the first piece of standalone cannabis legislation in US history to become law. It will reportedly streamline a new process for cannabis research applications and for manufacturing products for drug development and allow for a larger amount of legal cannabis for research purposes.

In partnership with the Cannabis Center of Excellence, MCR Labs Massachusetts held their second “Cannabis Science Fair” on the afternoon of December 3rd, 2022, as the final event of their Science Over Stigma campaign.

In their 2022 Census of Agriculture, the US Department of Agriculture will, for the first time, collect and publish data on farmers and producers who grow hemp for fabric, food products, and cannabidiol (CBD).

In this recent interview, Bruce Kendall and Dr. Hinanit Koltai of the Volcani Institute share the inspiring story of the late Michelle Kendall and how her passion for science and research brought them all together to study medical cannabis as a potential treatment for ovarian cancer.

The Cannabis & Me research study will reportedly study the effects of cannabis on the human brain, particularly in terms of a user’s prior psychological conditions.

Due to inflation and rising costs of living, Leaf411 resumed its affordability program to address the needs of patients seeking medical cannabis.